Document is current
Any future updates will be listed below
-
Authors
Komura, Kazumasa
Hirosuna, Kensuke
Tokushige, Satoshi
Tsujino, Takuya
Nishimura, Kazuki
Ishida, Mitsuaki
Hayashi, Takuo
Ura, Ayako
Ohno, Takaya
Yamazaki, Shogo
Nakamori, Keita
Kinoshita, Shoko
Maenosono, Ryoichi
Ajiro, Masahiko
Yoshikawa, Yuki
Takai, Tomoaki
Tsutsumi, Takeshi
Taniguchi, Kohei
Tanaka, Tomohito
Takahara, Kiyoshi
Konuma, Tsuyoshi
Inamoto, Teruo
Hirose, Yoshinobu
Ono, Fumihito
Shiraishi, Yuichi
Yoshimi, Akihide
Azuma, Haruhito
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H03070, 21H04828)
Naito Foundation
the Kenzo Suzuki Memorial Foundation
Japanese Urological Association
Japan Agency for Medical Research and Development (JP22jm0210085, JP22am0401007, and JP22ym0126804 (21-A-22))
National Cancer Center Research and Development Funds (2020-A-2 and 2023-S-6)
Takeda Science Foundation
- License Information
-
More Information
Article History
Received: 31 August 2023
Accepted: 6 November 2023
First Online: 18 November 2023
Declarations
:
: The study has been performed based on the principles of the World Medical Association Declaration of Helsinki. The study designs were approved by the institutional review board at Osaka Medical and Pharmaceutical University [OMPU-IRB approval number: No. 2305-11 (approval date: Nov 24th, 2017), No. 2344-10 (approval date: Nov 24th, 2017), No. 2523-3 (approval date: Jul 27th, 2018), No. 2808-2 (approval date: Jan 10th, 2020), No. 2571-6 (approval date: Nov 7th, 2018)]) and National Cancer Center Japan (NCC-IRB approval number: 2020–486, Date of approval: February 9th, 2021). All patients provided written informed consent prior to the analysis.
: All the authors, by giving their consent to participate, have given their consent for publication.
: The authors declare no conflict of interest.
